Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer

Recruiting

Conditions: Thyroid Cancer
Thyroid
Refractory Thyroid Cancer

Interventions: Other: Surveillance Visit

First Posted Date: 2023-02-17

Last Posted Date: 2025-04-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 100

Registration Number: NCT05733013

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer

Phase 2

Recruiting

Conditions: Breast Carcinoma
Breast Cancer

Interventions: Behavioral: Standard (fixed) Aerobic Training/AT dosing
Behavioral: Adaptive Aerobic Training/AT Dosing

First Posted Date: 2023-02-08

Last Posted Date: 2025-06-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 140

Registration Number: NCT05716893

Locations: 🇺🇸
Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 4 locations

A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis

Phase 1

Recruiting

Conditions: Myelofibrosis Due to and Following Polycythemia Vera

Interventions: Drug: Ruxolitinib
Drug: Abemaciclib

First Posted Date: 2023-02-06

Last Posted Date: 2025-02-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT05714072

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 4 locations

Retrospective Review of Esophageal Cancer at MSKCC

Recruiting

Conditions: Esophagus Cancer
Esophageal Cancer

Interventions: Procedure: Esophagectomy

First Posted Date: 2023-01-31

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 4000

Registration Number: NCT05706558

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

Early Phase 1

Recruiting

Conditions: Endometrial Cancer
Endometrial Carcinoma Stage III
Stage III Endometrial Carcinoma
Endometrial Carcinoma
Stage III Endometrial Cancer

Interventions: Radiation: Intensity-modulated radiation therapy
Drug: Carboplatin
Drug: Paclitaxel

First Posted Date: 2023-01-19

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT05691010

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All protocol activities), Montvale, New Jersey, United States

and more 4 locations

A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer

Phase 1

Active, not recruiting

Conditions: Solid Tumor
Solid Tumor, Adult
Solid Carcinoma
Metastatic Tumor
Metastatic Cancer
Metastatic Solid Tumor

Interventions: Drug: AZD1390
Radiation: Stereotactic Body Radiotherapy

First Posted Date: 2023-01-10

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 54

Registration Number: NCT05678010

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States

and more 2 locations

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

Phase 2

Recruiting

Conditions: Graft-Versus-Host Disease
Undefined
GVHD

Interventions: Device: Photobiomodulation Therapy
Other: Placebo sham device

First Posted Date: 2023-01-09

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 44

Registration Number: NCT05675930

Locations: 🇺🇸
National Institute of Health (Data Collection AND Specimen Analysis), Bethesda, Maryland, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States

and more 6 locations

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

Phase 2

Recruiting

Conditions: Adenocarcinoma of the Rectum
HER2 Positive Rectal Adenocarcinoma
Rectal Adenocarcinoma
Rectal Cancer
Locally Advanced Rectal Adenocarcinoma

Interventions: Drug: Trastuzumab
Drug: Tucatinib

First Posted Date: 2023-01-05

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 37

Registration Number: NCT05672524

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation

Phase 2

Recruiting

Conditions: Radiation Esophagitis

Interventions: Other: Usual Care
Other: Two consent
Other: One consent
Drug: Sucralfate

First Posted Date: 2022-12-21

Last Posted Date: 2024-10-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 352

Registration Number: NCT05659576

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York, United States

and more 4 locations

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

Phase 2

Recruiting

Conditions: Non Small Cell Lung Cancer
Non Small Cell Lung Cancer Metastatic
Non-small Cell Carcinoma
NSCLC
NSCLC Stage IV

Interventions: Radiation: L-SABR
Biological: Anti-PD-(L)1 based immunotherapy
Drug: Platinum based chemotherapy

First Posted Date: 2022-12-20

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 68

Registration Number: NCT05657873

Locations: 🇺🇸
BAPTIST ALLIANCE - MCI (Data Collection Only), Miami, Florida, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States

and more 6 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy